Son Lam

Son Lam has a diverse work experience in the field of biosciences and chemistry. Son is currently working as the Director of Chemistry at Avidity Biosciences, Inc. since February 2021. Prior to that, they held the position of Principal Scientist at Takeda from November 2019 to December 2021. From May 2018 to November 2019, Son Lam worked as a Director at Eurofins. Son also served as a Group Leader and Principal Scientist at Solstice Biologics from August 2013 to December 2017. Son Lam has also worked at CovX - Pfizer, where they held the positions of Principal Scientist from January 2011 to May 2013 and Senior Scientist from June 2008 to December 2010. Son started their career as a Postdoctoral Research Fellow at the National Institutes of Health from November 2003 to June 2008. Throughout their career, Son Lam has demonstrated their expertise in various areas, including antibody drug conjugates, peptide development, and structural studies related to HIV-1 entry.

Son Lam received a Ph.D. in Chemistry from the University of California, Davis, from 2001 to 2003. Prior to that, they obtained an M.S. in Chemistry from the University of Arizona, from 1997 to 2001. Son completed their undergraduate studies at Occidental College, earning an A.B. in Biochemistry from 1993 to 1997.